The protooncogene MYC can break B cell tolerance

被引:22
作者
Refaeli, Y
Field, KA
Turner, BC
Trumpp, A
Bishop, JM
机构
[1] Natl Jewish Med & Res Ctr, Dept Pediat, Denver, CO 80206 USA
[2] Univ Calif San Francisco, GW Hooper Fdn, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
[4] Univ Colorado, Ctr Canc, Aurora, CO 80211 USA
[5] Swiss Inst Expt Canc Res, Dept Genet & Stem Cells, CH-1066 Epalinges, Switzerland
关键词
autoimmunity lymphoma; lymphocyte; anergy; homeostasis;
D O I
10.1073/pnas.0409832102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The protooncogene MYC has been implicated in both the proliferation and programmed cell death of lymphoid cells, and in the genesis of lymphoid tumors. Here, we report that overexpression of MYC, as found in many lymphomas, can break immune tolerance. Mice that would otherwise be tolerant to a transgenic autoantigen mounted an immune response to the antigen if MYC was vigorously expressed in the B cell lineage. The responsive B cells converted to an activated phenotype and produced copious amounts of autoantibody that engendered immune complex disease of the kidney. MYC was required to both establish and maintain the breach of tolerance. These effects may be due to the ability of MYC to serve as a surrogate for cytokines. We found that the gene could mimic the effects of cytokines on both B cell proliferation and survival and, indeed, was required for those effects. These findings demonstrate a critical role for MYC in the response of B cells to antigen and expand the potential contributions of MYC to the genesis of lymphomas.
引用
收藏
页码:4097 / 4102
页数:6
相关论文
共 31 条
[21]   T-cell survival [J].
Marrack, P ;
Mitchell, T ;
Bender, J ;
Hildeman, D ;
Kedl, R ;
Teague, K ;
Kappler, J .
IMMUNOLOGICAL REVIEWS, 1998, 165 :279-285
[22]   3 DISTINCT IL-2 SIGNALING PATHWAYS MEDIATED BY BCL-2, C-MYC, AND LCK COOPERATE IN HEMATOPOIETIC-CELL PROLIFERATION [J].
MIYAZAKI, T ;
LIU, ZJ ;
KAWAHARA, A ;
MINAMI, Y ;
YAMADA, K ;
TSUJIMOTO, Y ;
BARSOUMIAN, EL ;
PERLMUTTER, RM ;
TANIGUCHI, T .
CELL, 1995, 81 (02) :223-231
[23]   MYC oncogenes and human neoplastic disease [J].
Nesbit, CE ;
Tersak, JM ;
Prochownik, EV .
ONCOGENE, 1999, 18 (19) :3004-3016
[24]   Clonal anergy of B cells: A flexible, reversible, and quantitative concept [J].
Nossal, GJV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :1953-1956
[25]   c-MYC: More than just a matter of life and death [J].
Pelengaris, S ;
Khan, M ;
Evan, G .
NATURE REVIEWS CANCER, 2002, 2 (10) :764-776
[26]   The chosen few? Positive selection and the generation of naive B lymphocytes [J].
Pillai, S .
IMMUNITY, 1999, 10 (05) :493-502
[27]   Mechanisms of apoptosis by c-Myc [J].
Prendergast, GC .
ONCOGENE, 1999, 18 (19) :2967-2987
[28]   Genetic models of abnormal apoptosis in lymphocytes [J].
Refaeli, Y ;
Van Parijs, L ;
Abbas, AK .
IMMUNOLOGICAL REVIEWS, 1999, 169 :273-282
[29]   Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis [J].
Refaeli, Y ;
Van Parijs, L ;
London, CA ;
Tschopp, J ;
Abbas, AK .
IMMUNITY, 1998, 8 (05) :615-623
[30]   c-Myc regulates mammalian body size by controlling cell number but not cell size [J].
Trumpp, A ;
Refaeli, Y ;
Oskarsson, T ;
Gasser, S ;
Murphy, M ;
Martin, GR ;
Bishop, JM .
NATURE, 2001, 414 (6865) :768-773